Shanghai, China

Jianchen Zhang

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Fujian Akeylink Biotechnology Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianchen Zhang. Retrieved from https://idiyas.com/inventor/jianchen-zhang-eptd93pl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jianchen Zhang in Biotechnology

Introduction

Jianchen Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly through his innovative research and development of peptide compounds. His work has implications for various pharmaceutical applications.

Latest Patents

Jianchen Zhang holds a patent for a ring-modified proline short peptide compound and its use. This patent discloses a compound represented by a specific formula or a pharmaceutically acceptable salt thereof. This innovation showcases his expertise in peptide chemistry and its potential therapeutic applications.

Career Highlights

Jianchen Zhang is associated with Fujian Akeylink Biotechnology Co., Ltd., where he continues to advance his research. His career is marked by a commitment to developing novel compounds that can lead to breakthroughs in medicine.

Collaborations

Jianchen has collaborated with notable colleagues such as Shuhui Chen and Yaxun Yang. These partnerships enhance the scope of his research and contribute to the advancement of biotechnology.

Conclusion

Jianchen Zhang's work exemplifies the innovative spirit in the field of biotechnology. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…